Unique ID issued by UMIN | UMIN000052193 |
---|---|
Receipt number | R000058725 |
Scientific Title | Additional impact of pancreatic juice cytology via endoscopic nasal pancreatic tube for the diagnosis of high-grade pancreatic intraepithelial neoplasia/ invasive pancreatic cancer without visible tumor by endoscopic ultrasound |
Date of disclosure of the study information | 2023/09/13 |
Last modified on | 2023/09/13 14:18:14 |
Additional impact of pancreatic juice cytology via endoscopic nasal pancreatic tube for the diagnosis of high-grade pancreatic intraepithelial neoplasia/ invasive pancreatic cancer without visible tumor by endoscopic ultrasound
Usefulness of pancreatic juice cytology via endoscopic nasal pancreatic tube for the diagnosis of early pancreatic cancer
Additional impact of pancreatic juice cytology via endoscopic nasal pancreatic tube for the diagnosis of high-grade pancreatic intraepithelial neoplasia/ invasive pancreatic cancer without visible tumor by endoscopic ultrasound
Usefulness of pancreatic juice cytology via endoscopic nasal pancreatic tube for the diagnosis of early pancreatic cancer
Japan |
high-grade pancreatic intraepithelial neoplasia/ invasive pancreatic cancer without visible tumor by endoscopic ultrasound
Hepato-biliary-pancreatic medicine |
Malignancy
NO
Evaluation of pancreatic juice cytology via endoscopic nasal pancreatic tube for the diagnosis of high-grade pancreatic intraepithelial neoplasia/ invasive pancreatic cancer without visible tumor by endoscopic ultrasound
Efficacy
Comparison of sensitivity, spesificity, accuracy, and area under curve of pancreatic juice cytology via endoscopic nasal pancreatic tube and those of single pancreatic juice cytology during endoscopic retrograde pancreatography.
Observational
20 | years-old | <= |
85 | years-old | > |
Male and Female
pancreatic juice cytology for patients with highly suspected small pancreatic cancer without visible mass by endoscopic ultrasound from May 2015 to April 2023.
First, PJC for the diagnosis of suspected intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia/carcinoma derive from IPMN was excluded because of the different nature of tumor. PJC for suspected PDAC with visible mass by EUS due to the failure diagnosis of EUS-FNAB was also excluded.
Patients with PJC positive results who underwent imaging follow-up less than one year without surgical resection and patients with PJC negative results who underwent imaging follow-up less than five years without surgical resection were excluded as undiagnosed cases, considering the progress nature/period of HG-PanIN and invasive PDAC.
22
1st name | Ryota |
Middle name | |
Last name | Sagami |
Oita San-ai Medical Center
Department of Gastroenterology
8701151
1213 Ichi, Oita, Oita, Japan
0975411311
sagami1985@yahoo.co.jp
1st name | Ryota |
Middle name | |
Last name | Sagami |
Oita San-ai Medical Center
Department of Gastroenterology
8701151
1213 Ichi, Oita, Oita, Japan
0975411311
sagami1985@yahoo.co.jp
Oita San-ai Medical Center
None
Other
Oita San-ai Medical Center
1213 Ichi, Oita, Oita, Japan
1975411311
sagami1985@yahoo.co.jp
NO
2023 | Year | 09 | Month | 13 | Day |
Unpublished
Open public recruiting
2023 | Year | 06 | Month | 29 | Day |
2023 | Year | 05 | Month | 19 | Day |
2023 | Year | 06 | Month | 29 | Day |
2025 | Year | 07 | Month | 01 | Day |
None declared
2023 | Year | 09 | Month | 13 | Day |
2023 | Year | 09 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058725